SCHEMBL26326203

SCHEMBL26326203

CC[Si](CC)(CC)OC(C)(C)CCC[C@@H](C)C1CC[C@H]2/C(=C/C=C3/CC(O[Si](C)(C)C(C)(C)C)C[C@H](N)C3)CCC[C@]12C

nearest known ligand 0.54

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ VDR P11473 12/20 0.54
▸ HDAC6 Q9UBN7 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26326175 1.00 VDR (0.54) VDRHDAC6
SCHEMBL26324070 0.93 VDR (0.62) VDRHDAC6
SCHEMBL26326695 0.92 VDR (0.54) VDR
SCHEMBL26322425 0.88 VDR (0.59) VDR
SCHEMBL14489200 0.88 VDR (0.61) VDR
SCHEMBL14489083 0.88 VDR (0.61) VDR
SCHEMBL26323531 0.87 VDR (0.55) VDR
SCHEMBL26323024 0.87 VDR (0.55) VDR
SCHEMBL26324018 0.86 VDR (0.57) VDR
SCHEMBL14356235 0.84 VDR (0.63) VDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230278955-A1 VITAMIN D3 DERIVATIVES AND PHARMACEUTICAL USE THEREOF UNIV KYOTO (JP) 2023-09-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230278955-A1 VITAMIN D3 DERIVATIVES AND PHARMACEUTICAL USE THEREOF VDR, CYP24A1, CYP2R1 VDR 1/4885HDAC6 3259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback